23.07
0.41 (1.81%)
| Previous Close | 22.66 |
| Volume | 798,064 |
| Price / Earnings (Forward) | 51.55 |
| Price / Sales | 3.37 |
| Price / Book | 3.11 |
| 52 Weeks Range |
| Profit Margin | -25.46% |
| Operating Margin (TTM) | -81.43% |
| Diluted EPS (TTM) | -1.44 |
| Quarterly Revenue Growth (YOY) | -44.90% |
| Quarterly Earnings Growth (YOY) | 107.20% |
| Total Debt/Equity (MRQ) | 10.48% |
| Current Ratio (MRQ) | 4.78 |
| Operating Cash Flow (TTM) | -11.69 M |
| Levered Free Cash Flow (TTM) | 10.73 M |
| Return on Assets (TTM) | -5.90% |
| Return on Equity (TTM) | -19.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Bullish | Mixed | |
| Stock | STAAR Surgical Company | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | -0.43 |
|
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Core |
| % Held by Insiders | 0.64% |
| % Held by Institutions | 109.43% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Yunqi Capital Ltd | 30 Jun 2026 | 3,257,130 |
| Anatole Investment Management Ltd | 30 Jun 2026 | 1,651,701 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |